Toumi et al.
7.80 (dd, J ) 8.5, 2.1 Hz, 1H), 7.67 (d, J ) 2.1 Hz, 1H), 7.17 (d,
J ) 8.5 Hz, 1H), 4.77-4.83 (m, 1H), 3.94 (s, 3H), 3.70 (s, 3H),
3.26 (A of ABX syst, J ) 14.0, 5.0 Hz, 1H), 3.09 (B of ABX syst,
J ) 14.0, 10.3 Hz, 1H), 2.67 (s, 3H), 1.29 (s, 9H); 13C NMR (75
MHz, DMSO-d6, 355 K): δ 190.3 and 190.2 (rotamers), 170.5,
162.1, 154.0 (br), 130.8, 130.6, 129.1, 126.4, 110.5, 78.7, 58.2 (br),
55.6, 51.3 and 51.2 (rotamers), 31.7, 29.1, 27.3; IR (neat): νmax
2970, 2837, 2735, 1737, 1685, 1603, 1501, 1439, 1260, 1173, 1030
cm-1; ESIMS (positive mode): 374.3, 318.2, 274.2; ESIHRMS m/z
calcd for C18H26NO6 [M + H]+ 352.1760, found 352.1789.
(S,Z)-Methyl 2-(tert-butoxycarbonyl-methyl-amino)-3-[5-(2-
iodo-vinyl)-2-methoxy-phenyl]-propionate. To a suspension of
iodomethyltriphenyl-phosphonium iodide (1.12 g, 2.11 mmol) in
THF (11 mL) was added dropwise at rt a solution of NaHMDS
(2.0 M solution in THF, 1.0 mL, 2.0 mmol). The resulting red-
orange solution was stirred at rt for 20 min and cooled to -78 °C
before adding HMPA (1.3 mL) and a solution of 11 (550 mg, 1.56
mmol) in THF (7 mL). The reaction mixture was stirred at -78
°C for 1 h and 40 min and quenched at -78 °C by addition of a
saturated aqueous solution of NaHCO3. The mixture was warmed
to rt, diluted with Et2O, and filtered through a plug of Celite which
was thoroughly washed with ether. The biphasic filtrate was
separated, and the organic layer was dried over MgSO4, filtered,
and concentrated. The crude residue was purified by flash chro-
matography over silica gel (AcOEt/petroleum ether: 25/75) to give
the desired vinyl iodide as a pale yellow oil (676 mg, 1.42 mmol,
91%). Diastereoisomeric excess was determined by analysis of crude
1H NMR spectra and was found to be higher than 95%. [R]D20 -66
and N-methylmorpholine (2.1 mL, 18.7 mmol) were successively
added at 0 °C, and the solution was stirred for 16 h while
progressively warmed to rt. The yellow slurry was finally concen-
trated and diluted with 1 M HCl aqueous solution. The aqueous
layer was extracted with CH2Cl2, and the combined organic layers
were dried over MgSO4, filtered, and concentrated to give the
desired dipeptide (2.3 g, 6.1 mmol, 81%) as a white solid. Mp:
212 °C; [R]D20 -20 (c 0.3, DMSO); 1H NMR (300 MHz, DMSO-
d6): δ 7.87 (d, J ) 8.3 Hz, 1H), 7.31-7.43 (m, 7H), 7.01 (s, 1H),
5.07 (s, 2H), 4.26-4.33 (m, 1H), 3.92 (t, J ) 8.0 Hz, 1H), 1.70-
1.77 (m, 1H), 1.54-1.67 (m, 1H), 1.41-1.51 (m, 3H), 1.07-1.23
(m, 1H), 0.91 (d, J ) 6.5 Hz, 3H), 0.81-0.87 (m, 9H); 13C NMR
(75 MHz, DMSO-d6): δ 173.9, 170.9, 156.1, 137.1, 128.3, 127.8,
127.6, 65.4, 59.3, 50.7, 41.0, 36.3, 24.4, 24.2, 23.0, 21.6, 15.4, 10.9;
IR (KBr): νmax 3385, 3314, 2945, 1670, 1639, 1537, 1235, 702
cm-1; ESIHRMS m/z calcd for C20H32N3O4 [M + H]+ 378.2393,
found 378.2401.
Isoleucine-leucinamide 12. A slurry of Cbz-isoleucine-leuci-
namide (600 mg, 1.59 mmol) in 95% ethanol (25 mL) was treated
with palladium on carbon (10 wt % on activated carbon, 100 mg)
and stirred under an atmosphere of hydrogen for 1 h. The mixture
was filtered over a plug of Celite and concentrated. The crude
residue was purified by flash chromatography over silica gel
(AcOEt/EtOH/30% aq NH3: 90/9/1) to give the desired peptide as
a white solid (364 mg, 1.50 mmol, 94%). Mp: 121 °C; [R]D20 -25
1
(c 2.0, MeOH); H NMR (300 MHz, MeOH-d4): δ 4.43 (dd, J )
9.1, 5.8 Hz, 1H), 3.21 (d, J ) 5.4 Hz, 1H), 1.44-1.77 (m, 5H),
1.09-1.26 (m, 1H), 0.88-0.98 (m, 12H); 13C NMR (75 MHz,
MeOH-d4): δ 177.4, 177.0, 60.9, 52.5, 42.3, 40.2, 25.9, 25.3, 23.4,
21.9, 16.1, 11.9; IR (KBr): νmax 3411, 3350, 2966, 1706, 1680,
1634, 1506, 1414, 850, 595 cm-1; ESIMS (positive mode): 266.3;
ESIHRMS m/z calcd for C12H26N3O2 [M + H]+ 244.2025, found
244.2035.
1
(c 1.0, CHCl3); H NMR (300 MHz, DMSO-d6, 355 K): δ 7.56
(dd, J ) 8.5, 2.2 Hz, 1H), 7.46 (d, J ) 2.2 Hz, 1H), 7.32 (d, J )
8.5 Hz, 1H), 7.01 (d, J ) 8.5 Hz, 1H), 6.55 (d, J ) 8.5 Hz, 1H),
4.77 (X of ABX syst, J ) 10.0, 4.8 Hz, 1H), 3.85 (s, 3H), 3.69 (s,
3H), 3.24 (A of ABX syst, J ) 14.0, 4.8 Hz, 1H), 3.00 (B of ABX
syst, J ) 14.0, 10.0 Hz, 1H), 2.68 (s, 3H), 1.29 (s, 9H); 13C NMR
(75 MHz, DMSO-d6, 355 K): δ 170.6, 157.2, 154.0, 137.3 and
137.2 (rotamers), 130.2 and 130.1 (rotamers), 128.2, 127.7 and
127.6 (rotamers), 125.1, 110.1, 78.6, 77.1, 58.4 (br), 55.2, 51.2 and
51.1 (rotamers), 31.8, 29.3, 27.4; IR (neat): νmax 2976, 2837, 2356,
1742, 1685, 1603, 1511, 1255, 1178, 1035, 825 cm-1; ESIMS
(positive mode): 498.1, 442.0, 398.1; ESIHRMS m/z calcd for
C19H27INO5 [M + H]+ 476.0934, found 476.0924.
(Z)-[N-Boc-N-Methyl-5-(2-iodo-vinyl)-2-methoxy-phenylala-
nyl]-isoleucine-leucinamide 13. To a solution of 3 (199 mg, 0.43
mmol) in DMF (1 mL) were successively added at 0 °C diisopro-
pylethylamine (83 µL, 0.47 mmol) and (benzotriazol-1-yloxy)-tris-
(dimethylamino)phosphonium hexafluorophosphate (BOP, 200 mg,
0.45 mmol). After stirring for 30 min at 0 °C, 12 (127 mg, 0.52
mmol) was added. The resulting mixture was slowly warmed to rt,
stirred overnight and quenched with a 10% aqueous citric acid
solution. The aqueous layer was extracted with ether, combined
organic layers were successively washed with a saturated aqueous
solution of NaHCO3 and brine, dried over MgSO4, filtered, and
concentrated. The crude residue was purified by flash chromatog-
raphy over silica gel (AcOEt/30% aq NH3: 99/1) to yield the desired
tripeptide 13 as a white solid (272 mg, 0.40 mmol, 92%). Mp: 89
(S,Z)-2-(tert-Butoxycarbonyl-methyl-amino)-3-[5-(2-iodo-vinyl)-
2-methoxy-phenyl]-propionic Acid 3. A solution of (S,Z)-methyl
2-(tert-butoxycarbonyl-methyl-amino)-3-[5-(2-iodo-vinyl)-2-meth-
oxy-phenyl]-propionate (310 mg, 0.65 mmol) in a mixture of MeOH
(2.6 mL), THF (0.7 mL), and water (0.7 mL) was treated with
lithium hydroxide monohydrate (55 mg, 1.30 mmol). The resulting
mixture was stirred at rt for 4 h, quenched by careful addition of
10 wt % aqueous citric acid solution, and extracted with ether.
Combined organic layer were dried over MgSO4, filtered, and
concentrated to give the desired amino acid fragment 3 as a white
sticky foam (291 mg, 0.63 mmol, 97%). [R]D20 -38 (c 1.3, CHCl3);
1H NMR (300 MHz, DMSO-d6, 345 K): δ 7.55 (dd, J ) 8.5, 1.9
Hz, 1H), 7.45 (d, J ) 1.9 Hz, 1H), 7.31 (d, J ) 8.5 Hz, 1H), 6.99
(d, J ) 8.5 Hz, 1H), 6.53 (d, J ) 8.5 Hz, 1H), 4.73 (br s, 1H), 3.84
(s, 3H), 3.22 (A of ABX syst, J ) 14.1, 4.5 Hz, 1H), 2.95 (B of
20
1
°C; [R]D -36 (c 0.7, CHCl3); H NMR (300 MHz, DMSO-d6,
345 K): δ 7.70 (d, J ) 8.0 Hz, 1H), 7.57 (dd, J ) 8.5, 2.2 Hz,
1H), 7.44 (d, J ) 2.2 Hz, 1H), 7.31 (d, J ) 8.5 Hz, 1H), 7.14 (d,
J ) 8.7 Hz, 1H), 6.81 (br s, 2H), 6.55 (d, J ) 8.5 Hz, 1H), 4.87 (X
of ABX syst, J ) 10.2, 4.8 Hz, 1H), 4.21-4.32 (m, 2H), 3.84 (s,
3H), 3.12 (A of ABX syst, J ) 14.5, 4.7 Hz, 1H), 2.95 (B of ABX
syst, J ) 14.5, 10.2 Hz, 1H), 2.71 (s, 3H), 1.76-1.87 (m, 1H),
1.55-1.70 (m, 1H), 1.39-1.53 (m, 3H), 1.30 (s, 9H), 1.03-1.11
(m, 1H), 0.91 (d, J ) 6.5 Hz, 3H), 0.81-0.88 (m, 9H); 13C NMR
(75 MHz, DMSO-d6, 345 K): δ 173.2, 170.0, 169.5, 157.2, 154.5
(br), 137.4, 129.9, 128.2, 127.3, 125.5, 110.0, 78.7, 77.3, 57.9 (br),
56.7, 55.2, 50.8 and 50.7 (rotamers), 40.7, 36.3, 30.2 (br), 28.1,
27.5, 23.9, 22.4, 21.3, 15.0, 10.3; IR (KBr): νmax 3288, 2955, 1675,
1644, 1506, 1260, 1153, 1020, 820 cm-1; ESIMS (positive mode):
709.3, 581.4; ESIHRMS m/z calcd for C30H48IN4O6 [M + H]+
687.2619, found 687.2577.
ABX syst, J ) 14.1, 10.8 Hz, 1H), 2.69 (s, 3H), 1.27 (s, 9H); 13
C
NMR (75 MHz, DMSO-d6, 345 K): δ 174.0, 157.4, 154.3 (br),
137.4, 130.2, 128.3, 127.7, 125.6, 110.1, 78.4, 77.1, 72.2, 55.2,
42.4, 31.5, 27.6; IR (neat): νmax 3293, 1736, 1708, 1450, 1127,
1035, 774 cm-1; ESIMS (positive mode): 484.0, 428.0, 384.1;
ESIHRMS m/z calcd for C18H25INO5 [M + H]+ 462.0777, found
462.0766.
Cbz-Isoleucine-leucinamide. Benzyloxycarbonyl-protected iso-
leucine (Z-Ile-OH, 2.0 g, 7.5 mmol), leucinamide hydrochloride
(H-Leu-NH2,HCl, 1.26 g, 7.5 mmol), and 1-hydroxy-7-azabenzo-
triazole (HOAt, 1.02 g, 7.5 mmol) were dissolved in DMF (50 mL).
The reaction mixture was cooled to 0 °C, 1-(3-dimethylaminopro-
pyl)-3-ethyl-carbodiimide hydrochloride (EDC, 1.44 g, 7.5 mmol)
N-Boc-Abyssenine A 14. A 50 mL flask was charged with iodo-
amide 13 (200 mg, 0.29 mmol), copper(I) iodide (11.1 mg, 0.06
mmol), and cesium carbonate (142 mg, 0.43 mmol). The flask was
evacuated under high vacuum, backfilled with argon, and closed
with a rubber septa. Dry and degassed THF (36 mL) and N,N′-
dimethylethylene-1,2-diamine (13 µL, 0.12 mmol) were next added,
9008 J. Org. Chem., Vol. 72, No. 24, 2007